BVC BATM Advanced Communications Ltd.

LSE · GB · Healthcare · Medical Instruments & Supplies · batm.com

11.00GBp+3.77%Mkt Cap: 40.66M $P/E: —Today

BATM Advanced Communications Ltd., together with its subsidiaries, engages in the development, production, and supply of real-time technologies and associated services in Israel, the United States, and Europe. It operate…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc. - Common Stock

$140.43BUSDP/E 44.8

EssilorLuxottica Société anonyme

$72.05BUSDP/E 27.0

BDX

Becton, Dickinson and Company Common Stock

$48.16BUSDP/E 30.5

MDLN

Medline Inc. - Class A common stock

$47.91BUSDP/E 44.5

RMD

ResMed Inc. Common Stock

Alcon Inc. Ordinary Shares

$30.82BUSDP/E 48.7

WST

West Pharmaceutical Services, Inc. Common Stock

$25.69BUSDP/E 46.8

DIM

Sartorius Stedim Biotech S.A.

$22.21BUSDP/E 69.8

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.16BUSDP/E 71.4

SOLV

Solventum Corporation Common Stock

$14.95BUSDP/E 10.7

BAX

Baxter International Inc. Common Stock

$12.14BUSD

COO

The Cooper Companies, Inc. - Common Stock

$10.82BUSDP/E 19.6

AVTR

Avantor, Inc. Common Stock

$10.38BUSD

COO

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

RGEN

Repligen Corporation - Common Stock

$10.25BUSDP/E 248.9

ALGN

Align Technology, Inc. - Common Stock

$10.21BUSDP/E 25.0

ATR

AptarGroup, Inc. Common Stock

$7.62BUSDP/E 21.6

Key Statistics

Company

Market Cap40.66M USD

Enterprise Value24.51M USD

Revenue (TTM)113.66M USD

Gross Profit37.91M USD

Net Income (TTM)-16.04M USD

Revenue/Share0.27 GBp

Last Price11.00 GBp

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees806

CountryGB

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)20.05

PEG—

EV/EBITDA11.04

EV/Revenue0.22

P/S0.34

P/B0.75

EPS (TTM)-0.03

EPS (Forward)0.01

52W Range

10.604% of range20.00

52W High20.00 GBp

52W Low10.60 GBp

Profitability

Gross Margin33.35%

Oper. Margin-3.36%

EBITDA Margin1.95%

Profit Margin-15.89%

ROE-18.40%

ROA0.15%

Growth

Revenue Growth-30.90%

Earnings Growth—

Cash Flow & Leverage

Operating CF-1.80M USD

CapEx (TTM)3.70M USD

FCF Margin11.82%

FCF Yield33.04%

Net Debt-13.01M USD

Net Debt/EBITDA-5.86

Balance Sheet

Debt/Equity17.05

Current Ratio1.95

Quick Ratio1.28

Book Value/Sh0.14 GBp

Cash/Share0.07 GBp

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 GBp

Div. Yield0.00%

5Y Avg Yield2.35%

Payout Ratio0.00%

Ex-Div DateDec 9, 2021

Pay Date—

Splits

Last Split10:1

Split DateJul 3, 2000

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.340.08M

Float236.07M

Insiders4.29%

Institutions40.24%

Technical

SMA 5011.95 (-8.0%)

SMA 20013.77 (-20.1%)

Beta0.73

S&P 52W Chg14.58%

Avg Vol (30d)191.18K

Avg Vol (10d)147.85K

Technical Indicators

RSI (14)24.8

MACD-0.3823

MACD Signal-0.3456

MACD Hist.-0.0367

BB Upper12.14 GBp

BB Middle11.39 GBp

BB Lower10.65 GBp

BB Width13.10%

ATR (14)0.5895 GBp

Vol Ratio (20d)0.24x